1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "198419-91-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-107515

    mGluR Neurological Disease
    LY367385 is a highly potent and selective mGluR1a antagonist. LY367385 has an IC50 of 8.8 μM for inhibits of quisqualate-induced phosphoinositide (PI) hydrolysis, compared with > 100 μM for mGlu5a. LY367385 has neuroprotective, anticonvulsant and antiepileptic effects.